Related Experiment Videos
Extranodal natural killer/T-cell lymphoma presenting as cavernous sinus syndrome
Hong-Cheng Mai1, Dan-Xia Chen1, Dan Lu1
1Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, P.R. China.
Molecular and Clinical Oncology
|April 18, 2017
Summary
Extranodal natural killer (NK)/T-cell lymphomas are rare, aggressive CNS tumors. Early FDG-PET/CT may aid diagnosis of these challenging lymphomas, which present unique clinical and imaging features.
Area of Science:
- Oncology
- Neurology
- Pathology
Background:
- Extranodal natural killer (NK)/T-cell lymphomas are rare, aggressive central nervous system (CNS) tumors.
- These lymphomas often affect the nasal cavity and paranasal sinuses, presenting with poor prognosis and challenging detection due to varied clinical and neuroimaging findings.
- Pathological examination is crucial for definitive diagnosis.
Purpose of the Study:
- To report a case of NK/T-cell lymphoma presenting with cavernous sinus syndrome via direct CNS extension from the nose.
- To highlight the diagnostic challenges and aggressive nature of these lymphomas.
Main Methods:
- Case report detailing clinical presentation, neuroimaging, and pathological findings.
- Discussion of fluorodeoxyglucose (FDG)-positron emission tomography combined with computed tomography (FDG-PET/CT) for lymphoma evaluation.
- Review of the literature on NK/T-cell lymphomas and their management.
Main Results:
- The case involved an NK/T-cell lymphoma extending from the nasal cavity to the CNS, causing cavernous sinus syndrome.
- The tumor exhibited characteristics typical of aggressive NK/T-cell lymphomas.
- FDG-PET/CT demonstrated avid uptake, suggesting its utility in evaluating such lymphomas.
Conclusions:
- NK/T-cell lymphomas are aggressive malignancies with poor outcomes and undefined optimal therapies.
- Early detection using methods like FDG-PET/CT may improve the evaluation of these challenging CNS lymphomas.
- Cavernous sinus syndrome can be a presenting manifestation of CNS NK/T-cell lymphoma due to direct extension.